Bank of America Merrill Lynch commented on McKesson MCK in a report released today. In the report, Bank of America Merrill Lynch was positive in its assessment of the company.
Bank of America Merrill Lynch writes, "MCK focused on strong, continuing fundamentals for its Distribution Solutions and Provider Technologies businesses, highlighting its diversified business model that affords it the broadest reach into the health care continuum, as well as its steady growth trajectory and continuing profit-margin leverage. Management reaffirmed its 2012 earnings guidance and quarterly progression, and our EPS estimates remain unchanged."
Bank of America Merrill Lynch currently has a Buy rating on McKesson and a price objective of $90. Shares of McKesson closed at $82.41 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst RatingsBank of America Merrill LynchHealth CareHealth Care Distributors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in